Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: a case report

The low incidence of secondary tumors to the testis is apparently due to the lower temperature of the scrotum, which could impair the metastatic ability of tumor cells from solid organs [7, 9].

Various routes of spread of metastatic tumors to the testes have been suggested, including arterial embolization, retrograde venous spread, retrograde lymphatic spread, direct spread along the vas deferens to the epididymis, and transperitoneal seeding through a patent tunica vaginalis. The dissemination mechanism seems to vary with type and location and the primary tumor, and one does not exclude the other [3, 10]. In general, for primary tumors that are located outside the pelvic and abdominal cavity, arterial dissemination seems to be the preferred route [11]. Given the absence of retroperitoneal lymphadenopathy, this was likely the case in our patient. Transperitoneal seeding is probable when peritoneal carcinomatosis is present [12].

Testicular metastases usually are a final manifestation of widely disseminated tumors, and therefore they often go unnoticed [6]. Rarely, they represent the first clinical manifestation of the underlying malignancy [4, 5], thus simulating a primary testicular tumor, as in our patient.

Clinically, there are no specific features that differentiate primary from secondary testicular tumors, as both may present with local pain, tenderness, nodular lesions, or an indurated testis; painless swelling, however, points toward the diagnosis of a testicular tumor. Also, serum tumor markers such as AFP and β-hCG are not helpful in distinguishing primary from secondary testicular tumors. On the one hand, normal values may be consistent with primary as well as secondary malignancies; on the other hand, elevated values may be related to gonadal as well as extragonadal tumors [5]. Interestingly, one of the few reported cases of pancreatic adenocarcinoma presenting as a testicular tumor featured raised hCG levels due to extragonadal secretion [13]. However, that patient was 77 years old, thus suggesting the testicular tumor to be a secondary rather than a primary malignancy. As a matter of fact, the patient’s age may play an important role in differentiating a primary tumor from a secondary one. Patients with testicular metastases are older than those with primary testicular tumors [14‐16], as the peak incidence of testicular metastases from all tumors is in the sixth decade of life, according to several large series reported in literature. Therefore, the peculiarity of our patient is that he was a young adult with bilateral hypogonadism and azoospermia, features that pointed toward the diagnosis of a primary testicular tumor. Pathologic examination is essential to differentiating primary from secondary testicular tumors. The first important feature is the absence of intratubular malignant germ cell neoplasms [16]. In the large series reported by García-González et al. [6], two architectural patterns were identified: an interstitial one, which can also be seen in primary tumors, though less frequently, and a destructive one, which was present in our patient. According to Price and Mostofi [14], another feature that increases the possibility of metastatic rather than primary tumor is the presence of tumor emboli in the vascular channels of the parenchyma and tunica albuginea, though intravascular invasion was very rarely found in another small series [6]. In our patient, no lymphovascular invasion was detectable in the testis.

Immunohistochemistry is nowadays regarded as the most sensitive and specific way of determining the origin of the tumor. Recently, new markers have been developed and are being used in diagnosis. These include homeobox protein NANOG, SOX2, and Oct-3/4 [17, 18]. In our patient, the histological diagnosis relied on positive immunohistochemical staining for CK7, CK20 (focal), and negative staining for PLAP, AFP, β-hCG, calretinin, inhibin, and a Ki67/MIB1 proliferation index of 15%, findings that were altogether consistent with metastatic adenocarcinoma of the pancreas. Serum CA 125 and CA 19-9 levels were within normal range, but abdominal computed tomography revealed the pancreatic tumor along with the hepatic metastases.